JW Lifescience Corporation (KRX:234080)
12,150
-370 (-2.96%)
At close: Aug 1, 2025, 3:30 PM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 188.14 billion as of August 1, 2025. Its market cap has increased by 3.23% in one year.
Market Cap
188.14B
Enterprise Value
226.97B
Revenue
243.33B
Ranking
n/a
PE Ratio
4.18
Stock Price
12,150.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 188.14B, a decrease of -44.67%. That is a compound annual growth rate of -6.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 188.14B | 11.67% |
Dec 30, 2024 | 168.47B | -15.46% |
Dec 28, 2023 | 199.29B | 5.93% |
Dec 29, 2022 | 188.14B | -12.27% |
Dec 30, 2021 | 214.46B | -34.73% |
Dec 30, 2020 | 328.57B | 4.80% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.59T |
Celltrion | 37.76T |
ALTEOGEN | 22.55T |
Yuhan | 8,432.74B |
SK Biopharmaceuticals | 7,345.78B |
Peptron | 6,523.26B |
HLB Co., Ltd. | 6,040.81B |
PharmaResearch | 5,724.70B |